The results of a crosssectional study conducted in the elderly U.S. Rancho Bernardo cohort demonstrated that individuals with MS had lower circulating levels of adiponectin compared to individuals without MS (68). This evidence concerns the gene ADIPOQ and myeloid sarcoma.